Note that our analysis here is limited to the genes found via our pipeline, and does not attempt to evaluate the annotations beyond analyzing the missed genes we found.
We analyzed the missing regions and found that they were caused primarily by low read coverage (0.2% in the largest human chromosome 1), clone ordering misassemblies (0.2%), tandem or nearby segmental duplications (0.3%), and highly enriched short, repetitive elements (1.1%), in total accounting for all but 0.6% of the original sequence.
An example of this behavior is given in the section analyzing the missing-value semantics of Nulls.
First, it is in a sense a "complete dataset", so when a dataset is analyzed with the missing values added back, one can see how much power has been lost.
When analyzing the impact of missing projections of markers, that is, occlusions, represented by and shown in Figure 6(a), it can be seen that the algorithm is still robust producing accurate estimations even in the case of a large miss of data,.
The feasibility of the FIM was assessed by analyzing the percentage of missing item responses and the average completion time.
In analyzing the number of missed genes by each center, we focused solely on analyzing the number of named missed genes, as we had good confidence that most of the named missed genes were true missed genes.
Using a merge-and-split based coalition formation game model, the authors in [13] analyze the average missed detection probability per CR.
By analyzing the reactions in which the missing species participated and comparing the SBML models to their description in the corresponding publications, we found the potential inconsistencies.
A clear difference between the two isoforms became obvious when analyzing the N-terminal constructs missing the catalytic kinase domain (aPKCζΔcatalytic and aPKCιΔcatalytic).
When analyzing the tumors that were missing for the 11q genes (102 out of 514), there was a tendency toward over-representation of lobular cancers and cancers of low grade and low proliferation, but there was no difference in breast cancer recurrences.
